Literature DB >> 14720121

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.

Julia Araya1, Ramón Rodrigo, Luis A Videla, Lilian Thielemann, Myriam Orellana, Paulina Pettinelli, Jaime Poniachik.   

Abstract

Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, triacylglycerols (triglycerides) and phospholipids of NAFLD patients in relation to those in adipose tissue and hepatic indexes related to oxidative stress as factors contributing to hepatic steatosis. Eleven control subjects and 19 patients with NAFLD were studied. Analysis of liver and abdominal adipose tissue fatty acids was carried out by GLC. The liver content of protein carbonyl groups and malondialdehyde were taken as indexes related to oxidative stress. NAFLD patients had a depletion in LCPUFA (long-chain PUFA) of the n -6 and n -3 series in liver triacylglycerols, with decreased 20:4, n -6/18:2, n -6 and (20:5, n -3+22:6, n -3)/18:3, n -3 ratios, whereas liver phospholipids contained higher n -6 and lower n -3 LCPUFA. These findings were accompanied by an enhancement of (i) n -6/ n -3 ratio in liver and adipose tissue, (ii) 18:1, n -9 trans levels in adipose tissue, and (iii) hepatic lipid peroxidation and protein oxidation indexes. It is concluded that a marked enhancement in LCPUFA n -6/ n -3 ratio occurs in the liver of NAFLD patients, a condition that may favour lipid synthesis over oxidation and secretion, thereby leading to steatosis. Depletion of hepatic LCPUFA may result from both defective desaturation of PUFA, due to inadequate intake of precursors, such as 18:3, n -3, and higher intake of the 18:1, n -9 trans isomer leading to desaturase inhibition, and from an increased peroxidation of LCPUFA due to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720121     DOI: 10.1042/CS20030326

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  194 in total

1.  Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.

Authors:  Jian-Hong Chu; Hui Wang; Yan Ye; Ping-Kei Chan; Si-Yuan Pan; Wang-Fun Fong; Zhi-Ling Yu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

Review 2.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

3.  In vivo characterization of the liver fat ¹H MR spectrum.

Authors:  Gavin Hamilton; Takeshi Yokoo; Mark Bydder; Irene Cruite; Michael E Schroeder; Claude B Sirlin; Michael S Middleton
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

4.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

Review 5.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

6.  "Trans-nonachlor increases extracellular free fatty acid accumulation and de novo lipogenesis to produce hepatic steatosis in McArdle-RH7777 cells".

Authors:  George Eli Howell; Erin McDevitt; Lucie Henein; Charlee Mulligan; Darian Young
Journal:  Toxicol In Vitro       Date:  2018-04-11       Impact factor: 3.500

7.  Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

Authors:  Mark Puder; Clarissa Valim; Jonathan A Meisel; Hau D Le; Vincent E de Meijer; Elizabeth M Robinson; Jing Zhou; Christopher Duggan; Kathleen M Gura
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

8.  In vivo triglyceride composition of abdominal adipose tissue measured by 1 H MRS at 3T.

Authors:  Gavin Hamilton; Alexandra N Schlein; Michael S Middleton; Catherine A Hooker; Tanya Wolfson; Anthony C Gamst; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2016-08-29       Impact factor: 4.813

Review 9.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

Review 10.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.